Provided by Tiger Trade Technology Pte. Ltd.

enVVeno Medical Corp.

11.85
+1.8618.62%
Post-market: 11.850.00000.00%19:49 EST
Volume:41.65K
Turnover:477.17K
Market Cap:7.75M
PE:-0.31
High:12.32
Open:10.27
Low:10.27
Close:9.99
52wk High:196.70
52wk Low:8.67
Shares:654.30K
Float Shares:503.00K
Volume Ratio:4.49
T/O Rate:8.28%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-37.8534
EPS(LYR):-44.5493
ROE:-57.19%
ROA:-35.12%
PB:0.26
PE(LYR):-0.27

Loading ...

Company Profile

Company Name:
enVVeno Medical Corp.
Exchange:
NASDAQ
Establishment Date:
1999
Employees:
37
Office Location:
70 Doppler,Irvine,California,United States
Zip Code:
92618
Fax:
- -
Introduction:
enVVeno Medical Corporation, a clinical-stage medical device company, focuses on the development of various bioprosthetic tissue-based solutions to enhance the standard of care in the treatment of venous diseases. The company's lead product is the VenoValve, a surgical implant being developed for the treatment of venous Chronic Venous Insufficiency. Its VenoValve is implanted in the femoral vein and acts as a one-way valve to help restore proper blood flow in the leg; and enVVe, a non-surgical, transcatheter based replacement venous valve for the treatment of CVI. The company was formerly known as Hancock Jaffe Laboratories, Inc. and changed its name to enVVeno Medical Corporation in October 2021. enVVeno Medical Corporation was incorporated in 1999 and is based in Irvine, California.

Directors

Name
Position
Robert A. Berman
Chief Executive Officer and Director
Francis Duhay
Independent Director
Matthew M. Jenusaitis
Independent Director
Robert C. Gray
Independent Director
Sanjay Shrivastava
Independent Director

Shareholders

Name
Position
Robert A. Berman
Chief Executive Officer and Director
Hamed Alavi
Chief Technology Officer and Senior Vice President
Jennifer Bright
Chief Financial Officer
Marc H. Glickman
Chief Medical Officer and Senior Vice President